Clinical Trial Update: Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing the efficacy and safety of lixisenatide versus insulin glulisine as add-on to insulin glargine, with or without metformin, in adults w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Adlyxin (lixisenatide) (lixisenatide)
• Apidra (insulin glulisine) (insulin glulisine)
• Glucophage (metformin) (metformin)
• Lantus (insulin glargine) (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2017-01-04